Longevity Daily
The most relevant research on longevity, biohacking, and regenerative medicine — straight from the world’s best sources. No marketing filters.
NAD+ reverses age-related muscle loss: the finding that reframes aging science
A study published in Nature Metabolism demonstrates that restoring NAD+ levels in aged mice reverses key markers of sarcopenia, opening an unprecedented window toward intervening in age-related muscle decline. The findings validate what longevity researchers have long theorized: that mitochondrial metabolic decline is not inevitable, but reversible through reactivation of cellular energy pathways. This conclusion transforms the logic of three human supplementation strategies already available in the premium biohacking market—NMN, NR, and intravenous NAD+ therapy—from mere preventive adjuncts into potentially regenerative interventions. For those seeking not only to add years to life but muscle and function to those years, this represents the first rigorous clinical evidence supporting the protocol.
Hyperbaric oxygen reduces senescent T cells by 37%: scientific confirmation of a rejuvenation mechanism
A replication study published in Aging confirms the seminal findings of Shamir et al. (2020): sixty sessions of hyperbaric oxygen therapy at 2 ATA significantly reduce CD28null senescent T cells and induce telomere lengthening in peripheral blood lymphocytes. This experimental validation closes a critical gap in understanding immune aging, demonstrating that an accessible and repeatable protocol produces quantifiable molecular changes. For longevity practitioners, the signal is unambiguous: there now exists a demonstrated mechanism to reverse one of the most robust markers of immune senescence, raising an uncomfortable question about why hyperbaric therapy remains peripheral in healthy aging protocols.
Senolytics: First Human Trial Confirms Reduction in Frailty Markers
A phase 2 trial from Mayo Clinic has demonstrated that the combination of dasatinib and quercetin significantly reduces senescent cell burden in older adults with frailty, improving their physical function within three months. This finding marks the first concrete clinical result of a strategy aging biology has pursued for years: selectively eliminating the damaged cells that accumulate with age and drive chronic inflammation. The magnitude of improvement in frailty markers opens an unexpected door for pharmacological interventions in the functional decline linked to cellular senescence, transforming laboratory observation into actionable therapeutic option.
DunedinPACE: the epigenetic clock revealing your true aging velocity
DunedinPACE represents a qualitative leap in measuring not how many years you have lived, but how fast you are aging right now. Unlike traditional biomarkers offering static snapshots of health, this instrument detects shifts in aging rate with unprecedented sensitivity, enabling you to evaluate which interventions—from exercise protocols to metabolic shifts—produce measurable results. For the high-performance biohacking audience, this means moving beyond vanity metrics toward data reflecting the genuine impact of each decision on your longevity trajectory. The implication is profound: for the first time, you can iterate on your own biology with objective feedback, transforming aging from an inevitable process into a variable responsive to deliberate intervention.
Exosomes versus stem cells: what joint regeneration gains in 2026
A comprehensive review of exosome therapies for osteoarthritis marks a clinical inflection point: these extracellular vesicles demonstrate superior safety profiles compared to mesenchymal stem cell injections while maintaining comparable efficacy at twelve months according to available phase 2 trials. This finding reframes the risk-benefit equation guiding regenerative medicine decisions in joint care, where differential tolerability becomes clinically material for populations with multiple comorbidities. For those pursuing premium joint regeneration and cartilage preservation protocols, the 2026 evidence suggests exosomes represent a lower immunological burden alternative without compromising regenerative performance over the medium term.
Photobiomodulation at 810 nm: how red light restores ATP in aging muscle
A new mechanistic study confirms what longevity protocols have long suggested: near-infrared light at 810 nanometers directly activates mitochondrial cytochrome c oxidase, increasing ATP production by 30% in aged myocytes. This cellular energy boost is not cosmetic—it represents the difference between muscle tissue that progressively atrophies and tissue that maintains contractile and metabolic capacity through later decades. For those pursuing functional age reversal, this data transforms photobiomodulation from a complementary tool into an intervention with solid mechanistic backing, validating its integration into tissue regeneration protocols.
Get it weekly in your inbox
The most comprehensive weekly longevity digest. No spam. Only the best of real science.
Subscribe to newsletterComing soon. Generate your protocol with My Protocol to be the first.